Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 25Breast Neoplasms 22Salivary Gland Neoplasms 3Prostate Adenocarcinoma 2Neoplasm Metastasis 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunctions, Psychological 1Primary Dysautonomias 1Patient Compliance 1PSA Level Greater Than Two 1Kidney Diseases 1Hypertension 1Hormone Sensitive Prostate Cancer 1Hereditary Sensory and Autonomic Neuropathies 1HER2-positive Breast Cancer 1HER2 Negative Breast Cancer 1Castrate Sensitive Prostate Cancer 1Bulbo-Spinal Atrophy, X-Linked 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Breast Cancer 1

Interventions

Specimen Handling 9Practice Guidelines as Topic 7Standard of Care 6Taxes 4Paclitaxel 4Early Intervention, Educational 4Docetaxel 4pertuzumab 3Trastuzumab 3Methods 3Educational Status 3trastuzumab biosimilar HLX02 2pembrolizumab 2PF-05280014 2Ontruzant 2Ogivri 2Minoxidil 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2High-Energy Shock Waves 2Cyclophosphamide 2Carboplatin 2Biopsy 22C4 antibody 2regadenoson 1nilotinib 1fisetin 1abemaciclib 1Yoga 1X-Ray Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage I Breast Cancer AJCC v8 × Goserelin × 1 year × Clear all
NCT07460752 2026-03-10

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Mayo Clinic

Phase 2 Not yet recruiting
98 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡